Sims Joshua Joyner patents

• Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

  US-2026049334-A1 · Feb 19, 2026 · US

• Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor

  US-12416016-B2 · Sep 16, 2025 · US

• Aav capsids for improved heart transduction and detargeting of liver

  US-2025144243-A1 · May 8, 2025 · US

• Compositions comprising a lipolytic enzyme variant and methods of use thereof

  US-2024279627-A1 · Aug 22, 2024 · US

• Novel compositions with brain-specific targeting motifs and compositions containing same

  US-2024207452-A1 · Jun 27, 2024 · US

• Novel compositions with tissue-specific targeting motifs and compositions containing same

  US-2024024507-A1 · Jan 25, 2024 · US

• Compositions and method of use of mutant ace2 decoy variants

  US-2023338478-A1 · Oct 26, 2023 · US

• Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

  US-2021123073-A1 · Apr 29, 2021 · US

• Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

  US-2020407750-A1 · Dec 31, 2020 · US

No data yet.